Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. [electronic resource]
Producer: 20001003Description: S121-7 p. digitalISSN:- 0957-5235
- Adult
- Aged
- Blood Coagulation -- drug effects
- Blood Loss, Surgical -- prevention & control
- Child, Preschool
- Factor VIIa -- administration & dosage
- Female
- Heart Valve Prosthesis Implantation
- Heart Valves -- surgery
- Humans
- Middle Aged
- Postoperative Hemorrhage -- drug therapy
- Recombinant Proteins -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.